ERVs trigger dsRNA stress and the interferon response, resulting in the recruitment of anti-tumour T-cells, and increased expression of PD-L1 with sensitisation to anti-PD-L1 blockade in multiple cancer models (198). The gene discussed is CD274; the disease is cancer.